Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1992-7-14
pubmed:abstractText
We investigated the capacity of T lymphocytes from a leukocyte adhesion-deficient (LAD) patient to respond to alloantigen. Leukocytes of this patient completely lacked LFA-1 surface expression due to the absence of mRNA coding for the LFA-1 beta chain. Despite the absence of LFA-1, T lymphocytes obtained from this patient, cultured with allogeneic stimulator cells (lymphoblastoid B cells JY), were capable of lysing JY cells. Furthermore, two T cell clones (one CD4+ and one CD8+), generated from this lymphocyte culture, specifically lysed the allogeneic lymphoblastoid JY cells. The cytolytic capacity of LFA-1-negative T lymphocytes and T cell clones was comparable to that of control LFA-1-positive T cells with allospecificity against JY. Detailed analysis of the CD4 positive and LFA-1-negative T cell clone demonstrated that it specifically recognized HLA-DQ. Antibody inhibition studies showed that the CTL/target cell interaction was mediated through the CD2/LFA-3 adhesion pathway. LFA-1 expressed by the target cells did not participate in the CTL/target cell conjugate formation and contributed only minimally to the cytotoxic activity. Moreover, when allogeneic LFA-1-deficient B cells, bearing the appropriate HLA-DQ alloantigen, were used as target cells, significant levels of specific cytotoxicity were measured, further excluding a role for LFA-1 in this interaction. The adhesion molecules, VLA-4, CD44 and L-selectin (LECAM1) were not involved. These results demonstrate that LFA-1-negative T lymphocytes can exert allospecific cytotoxicity and that CTL/target cell contact is mediated through the CD2/LFA-3 route. This observation may explain in part why in LAD patients viral infections, cleared largely by T cells, are less frequently observed than bacterial infections, in which phagocytic cells play a major role.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD2, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD58, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation..., http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface, http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules, http://linkedlifedata.com/resource/pubmed/chemical/GZMA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Granzymes, http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1, http://linkedlifedata.com/resource/pubmed/chemical/Lymphocyte Function-Associated..., http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0014-2980
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1467-75
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:1376259-Antibodies, Monoclonal, pubmed-meshheading:1376259-Antigens, CD, pubmed-meshheading:1376259-Antigens, CD2, pubmed-meshheading:1376259-Antigens, CD58, pubmed-meshheading:1376259-Antigens, Differentiation, T-Lymphocyte, pubmed-meshheading:1376259-Antigens, Surface, pubmed-meshheading:1376259-B-Lymphocytes, pubmed-meshheading:1376259-Blotting, Northern, pubmed-meshheading:1376259-CD4-Positive T-Lymphocytes, pubmed-meshheading:1376259-Cell Adhesion, pubmed-meshheading:1376259-Cell Adhesion Molecules, pubmed-meshheading:1376259-Cell Division, pubmed-meshheading:1376259-Clone Cells, pubmed-meshheading:1376259-Cytotoxicity, Immunologic, pubmed-meshheading:1376259-Flow Cytometry, pubmed-meshheading:1376259-Granzymes, pubmed-meshheading:1376259-HLA-DQ Antigens, pubmed-meshheading:1376259-Humans, pubmed-meshheading:1376259-Immunity, Cellular, pubmed-meshheading:1376259-Immunophenotyping, pubmed-meshheading:1376259-Intercellular Adhesion Molecule-1, pubmed-meshheading:1376259-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:1376259-Membrane Glycoproteins, pubmed-meshheading:1376259-RNA, pubmed-meshheading:1376259-Receptors, Immunologic, pubmed-meshheading:1376259-Serine Endopeptidases, pubmed-meshheading:1376259-T-Lymphocytes, pubmed-meshheading:1376259-T-Lymphocytes, Cytotoxic
pubmed:year
1992
pubmed:articleTitle
Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
pubmed:affiliation
Division of Immunology, The Netherlands Cancer Institute, Amsterdam.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't